CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Lenire nun in den klinischen Praxisleitlinien der US-amerikanischen HNO-Gesellschaft aufgenommen - erste neue Behandlungsmethode, die von der American Academy of Otolaryngology seit der Einführung ihrer Tinnitus-Leitlinien hinzugefügt wurde

RegulatorypositiveLenirePositive
AI Analysis

Summary

The American Academy of Otolaryngology – Head and Neck Surgery Foundation has included Lenire (bimodal neuromodulation) as a treatment option in its clinical practice guidelines for tinnitus. It is the only new treatment recommendation added since the guidelines were introduced.

Outcome Details

Lenire was added to the American Academy of Otolaryngology – Head and Neck Surgery Foundation clinical practice guidelines for tinnitus as a treatment option; it is the only new treatment recommendation added since the guidelines were introduced.

Importance:5/10
Sentiment:
0.70
tinnitusclinical practice guidelinesmedical deviceneuromodulationAAO-HNSFLenire
Related Companies

Read the original article

Published by PR Newswire Pharma on October 19, 2026 5:46 AM

Read Original